Respiratory · 38 CFR 4.97 · Diagnostic Code 6602
Asthma VA Disability Rating
TL;DR. Asthma rates under DC 6602 at 10 / 30 / 60 / 100% based on three alternative inputs: FEV1% predicted, FEV1/FVC ratio, or medication requirements (with monthly-visit and steroid-course alternatives at higher brackets). The rater applies the worst-of-three. PACT Act (2022) added asthma diagnosed after service to the burn-pit presumptive list under 38 CFR 3.320 for qualifying post-9/11 veterans — Iraq, Afghanistan, Kuwait, Saudi Arabia, Syria, Djibouti, Somalia, plus other locations. Pre-9/11 Gulf War veterans have separate pathways. Document PFT results, every inhaler, every oral steroid course, and every ER visit.
What asthma means in VA disability terms
Asthma is a chronic inflammatory airway disease characterized by reversible airflow obstruction, bronchial hyperresponsiveness, and inflammation. The VA rates asthma functionally based on pulmonary function tests (PFTs) and treatment intensity. The diagnosis itself is established by pulmonologist or primary-care documentation.
Full DC 6602 criteria
| Rating | Criteria (worst-of-three applies) |
|---|---|
| 10% | FEV1 of 71 to 80 percent predicted; OR FEV1/FVC of 71 to 80 percent; OR intermittent inhalational or oral bronchodilator therapy. |
| 30% | FEV1 of 56 to 70 percent predicted; OR FEV1/FVC of 56 to 70 percent; OR daily inhalational or oral bronchodilator therapy; OR inhalational anti-inflammatory medication. |
| 60% | FEV1 of 40 to 55 percent predicted; OR FEV1/FVC of 40 to 55 percent; OR at least monthly visits to a physician for required care of exacerbations; OR intermittent (at least three per year) courses of systemic (oral or parenteral) corticosteroids. |
| 100% | FEV1 less than 40 percent predicted; OR FEV1/FVC less than 40 percent; OR more than one attack per week with episodes of respiratory failure; OR requires daily use of systemic (oral or parenteral) high-dose corticosteroids or immuno-suppressive medications. |
The medication-path leverage
Many veterans whose PFTs are borderline still qualify for higher brackets via the medication path:
- 10% via intermittent rescue inhaler (albuterol PRN).
- 30% via daily controller medication (fluticasone/budesonide inhaled, montelukast oral, daily long-acting bronchodilator).
- 60% via ≥3 oral prednisone courses per year for exacerbations.
- 100% via daily high-dose oral steroids or biologic immunosuppressants (omalizumab, mepolizumab, dupilumab daily/regular).
Document every prescription. The medication path frequently produces a higher rating than the PFT path.
Service-connection paths
PACT Act burn-pit presumption (post-9/11)
The PACT Act of 2022 added asthma diagnosed after service to the burn-pit presumptive list under 38 CFR 3.320. Qualifying locations include Afghanistan, Iraq, Kuwait, Saudi Arabia, the broader Southwest Asia theater, Syria, Djibouti, Egypt, Jordan, Lebanon, Yemen, Uzbekistan, plus other listed locations. Qualifying dates are typically Sept 11, 2001 onward (Aug 2, 1990 onward for traditional Gulf War theater).
Check PACT Act eligibility →Gulf War presumption (pre-9/11)
Asthma is not on the original Gulf War MUCMI list (which is fibromyalgia / CFS / IBS), but the PACT Act expansion brought asthma in for the broader airborne-hazards theater.
Direct service connection
For non-Gulf War / non-PACT-Act veterans, direct service connection requires in-service onset (asthma diagnosed during active duty, with confirmatory STRs) or onset within one year of separation under chronic-disease presumption.
Secondary service connection
Asthma can be secondary to GERD (acid reflux triggers bronchospasm), allergic rhinitis (united-airway theory), and chronic sinusitis. These secondary pathways are recognized but less commonly used than the presumptive pathways for qualifying veterans.
Evidence the VA looks for
- Pulmonary function tests. Pre- and post-bronchodilator FEV1, FVC, and FEV1/FVC. Reversibility (improvement after bronchodilator) supports the asthma diagnosis vs COPD.
- Medication list. Inhalers (rescue and controller), oral medications, biologic therapy.
- Steroid-course documentation. Each oral prednisone burst for an exacerbation should be in the medical record with start/stop dates.
- ER / urgent-care visits. Asthma exacerbations seen in acute care.
- Pulmonologist notes. Specialist follow-up records.
- For PACT Act: DD-214 with qualifying service dates and locations.
The C&P exam for asthma
The asthma C&P exam uses DBQ for Respiratory Conditions (Bronchial Asthma). Key elements:
- PFT results (the examiner may order if recent ones are not in the record).
- Current medications and frequency.
- Exacerbation history (past 12 months).
- ER / hospital visits.
- Oral steroid courses (number per year).
- Functional impact on work and ADLs.
Preparation tips:
- Bring recent PFTs. Ideally within the past 12 months.
- Bring a medication list with dosing frequency.
- Document every exacerbation with dates and treatment received.
- Do not perform PFT on a steroid-controlled day if your baseline is worse. Examiners should test on a representative day; mention if you've recently been on prednisone.
Common rating pitfalls
- Borderline PFTs without medication-path consideration. A veteran with FEV1 75% who uses daily inhaled steroids should be at 30% via the medication path, not 10% via the PFT path.
- Missing the PACT Act presumption. Post-9/11 veterans with asthma diagnosed after service almost always qualify. If denied pre-2022, file Supplemental Claim citing the regulation.
- Not documenting oral steroid courses. Each prednisone burst counts. Three or more per year drives 60%.
- Filing asthma without claiming GERD / allergic rhinitis. Common comorbidities, each rateable separately when present.
- Stale PFTs from years ago. Request updated PFTs if symptoms have progressed.
Worked example
Veteran: Army, deployed Iraq 2007-2008 and Afghanistan 2011-2012. Diagnosed asthma 2018. Daily fluticasone/salmeterol controller + as-needed albuterol. Three prednisone courses in 2024 for exacerbations. PFT 2024: FEV1 68% predicted. Spouse.
- Asthma DC 6602: Worst of (1) PFT FEV1 68% = 30% bracket, (2) daily controller medication = 30% bracket, (3) 3 oral steroid courses/year = 60% bracket. Rating: 60%.
- Service connection: PACT Act burn-pit presumption (Iraq + Afghanistan qualifying service).
- 2026 monthly compensation (veteran + spouse, 60%): $1,566.02/mo.
The oral steroid courses are the dispositive factor — without them, the rating would be 30% ($622.04). Document every steroid burst.
Common secondary conditions
- GERD. Acid reflux into upper airways triggers bronchospasm. Rate separately under DC 7346.
- Allergic rhinitis. United-airway concept — same inflammation, upper airway. Rate separately.
- Chronic sinusitis. Recurrent sinusitis is common in asthmatics. Rate separately under DC 6510-6514.
- Sleep apnea. Independent claim if confirmed by sleep study.
Sources cited in this article
- 38 CFR 4.97 — The Respiratory System (DC 6602)
- 38 CFR 3.320 — Toxic exposure presumptive (PACT Act implementation)
- VA.gov — Toxic exposure
- PACT Act of 2022 (H.R. 3967)
VetDisabilityCalc is an independent reference site. We are not VA-accredited and we do not prepare or present VA claims.